Celgene
NASDAQ: CELG
$108.24
+$0.00 (+0.0%)
Closing Price on November 22, 2019
CELG Articles
ThinkstockStocks have pulled back ahead of the jobs data, and investors need to be considering how to position their portfolios going into year-end and 2014. 24/7 Wall St. reviews many Wall Street...
Published:
OncoMed Pharmaceuticals just went from being an obscure biotech to one on the map with more security than it had. The company can thank Celgene for this development.
Published:
ThinkstockThe field of pharmaceuticals is very well established and often is considered to be a very defensive sector. As such, investors flock to the drug sector in times of uncertainty. But what...
Published:
Jon OggStocks have traded down from recent highs in light of a federal government shutdown and ahead of a debt ceiling expiration. Now investors and traders have to wonder which stocks to buy and...
Published:
ThinkstockTuesday saw the wrap up of the 2013 European Society of Medical Oncology (ESMO) conference in Amsterdam, which featured key data from several of the companies covered by the biotech...
Published:
ThinkstockThe higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale in to their portfolios. With the market currently teetering on what seems like an...
Published:
Last Updated:
ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA) approval or a life-saving capital raise is the difference...
Published:
Last Updated:
ThinkstockBiotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the 28%...
Published:
Last Updated:
Jon OggBiotech stocks come and go as far as the flavor of the day for investors. While many of these companies are risky, and while many are too risky for many investors, what investors need to know...
Published:
Last Updated:
Jon OggInvestors and traders are usually on the hunt for new ideas that will generate positive returns or income. 24/7 Wall St. looks over numerous research calls to find great ideas from value...
Published:
Last Updated:
Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the sector...
Published:
courtesy of the Walt Disney Co.You know it is a bull market when you see major household names hitting 52-week highs. Right now we have many major stocks hitting fresh all-time highs! Should you be...
Published:
Last Updated:
ThinkstockWhen companies start buying back their common stock on the open market, it can have multiple outcomes. It can offset employee stock option dilution, and it can lower the public share float....
Published:
ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary event that...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Monday. AK Steel Holding Corp. (NYSE: AKS) cut to Sell at Goldman Sachs. Apple...
Published:
Last Updated: